Press "Enter" to skip to content

NSCLC Patients With Liver Tumors Live Longer On Tecentriq, Study Finds – Immuno-Oncology News

admin 0

NSCLC Patients With Liver Tumors Live Longer On Tecentriq, Study Finds  Immuno-Oncology News

A combination of Tecentriq, Avastin, and chemotherapy cut the risk of death by nearly half in NSCLC patients with liver metastasis, a study finds.

“lung cancer” – Google News

(Visited 5 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *